您的位置: 首页 > 农业专利 > 详情页

Variant antibodies that bind AIP2
专利权人:
Sorrento Therapeutics; Inc.
发明人:
Yanliang Zhang,Gunnar F. Kaufmann
申请号:
US16228570
公开号:
US10774135B2
申请日:
2018.12.20
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present disclosure provides fully human variant anti-AIP2 variant antibodies, and antigen binding proteins thereof, having improved characteristics compared to the wild type anti-AIP2 antibody E7 from which the variant clones are derived. The variant anti-AIP2 antibodies exhibit improved binding to AIP1 and AIP4 as determined in an in vitro quorum sensing reporter assay, have improved thermal stability, provided complete protection against infection with two different strains of Staphylococcus aureus MRSA in pre-treated mice, and can be manufactured at higher yields.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充